Clinical trial
Carmat TAH Early Feasibility Study
NCT04117295 · Carmat SAS, Industry · Suspended
Key facts
| NCT number | NCT04117295 |
|---|---|
| Title | Carmat TAH Early Feasibility Study |
| Official title | Carmat Total Artificial Heart Early Feasibility Study |
| Lead sponsor | Carmat SAS, Industry |
| Status | Suspended |
| Study type | Interventional |
| Conditions | End-stage Heart Failure |
| Intervention type | Device |
| Interventions | Carmat Total Artificial Heart |
| Enrollment | 10 |
| Start date | Jul 12, 2021 |
| Primary completion | Apr 1, 2026 |
| Completion | Jan 1, 2027 |
| First posted | Oct 7, 2019 |
| Last update posted | Jan 28, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: